Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from IDT Australia Limited ( (AU:IDT) ).
IDT Australia Limited has finalized a new $20 million loan facility with Scottish Pacific Business Finance, replacing a previous $4.7 million facility. This new financial arrangement is set to enhance IDT’s capacity to expand its operations in response to increased demand and market opportunities, reflected by a substantial year-on-year revenue increase.
More about IDT Australia Limited
IDT (ASX:IDT) is an Australian pharmaceutical manufacturing company based in Boronia, Victoria, specializing in high potency and high containment pharmaceutical products. It offers comprehensive services for drug development and manufacture for both local and international clients, maintaining compliance with US FDA and Australian TGA standards.
YTD Price Performance: -4.55%
Average Trading Volume: 124,680
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$43.44M
For an in-depth examination of IDT stock, go to TipRanks’ Stock Analysis page.